Winter 2023 Magazine
Message from Duke Ob/Gyn Chair Matthew D. Barber, MD, MHS
Study Shows Faster Return to Activity After Prolapse Surgery Is Recommended
Top IUD TikTok Videos Often Portray Painful Experiences, Health Care Mistrust
By Alexis Porter, Duke Health News Office
Popular TikTok videos related to intrauterine devices (IUDs) tend to depict negative patient experiences related to pain, while some videos conveyed unreliable information about the contraceptive devices.
Duke Health researchers Jonas Swartz, MD, MPH, medical director of Family Planning and Ryan Program Director, and Jenny Wu, MD, Duke Ob/Gyn resident, led the study published Dec. 6, 2022, in Obstetrics & Gynecology.
Engineering Smart Therapeutics: Innovative Uterine Fibroid Treatment
By Ben Miller, MFA, PMP, Duke Clinical and Translational Science Institute
A collaboration by researchers at Duke and North Carolina Central University (NCCU) aims to offer a more convenient, less invasive treatment for uterine fibroids, one of the most common and under-studied issues in women’s health.
Hormone Therapy Appears To Reduce Risk of Shoulder Pain in Older Women
Preliminary study finds use of hormone replacement therapy might reduce risk of a painful shoulder condition called adhesive capsulitis
By Sarah Avery, Duke Health News Office
Post-menopausal women on hormone replacement therapy had a lower risk of developing a painful shoulder condition known as adhesive capsulitis compared to women who did not receive estrogen, according to a study led by Duke Health researchers.
Helping Patients With Müllerian Anomalies Navigate Care
Translating Cervical Cancer Algorithms to Rapid Diagnosis Mechanisms
Megan Huchko, MD, MPH, Hollier Family Associate Professor of Global Health and Ob/Gyn, is co-primary investigator with the Center for Global Women’s Health Technologies Director Nimmi Ramanujam, PhD, on a new $3 million award to explore technologies to improve cervical cancer screening in low-resource settings.
PFAS Contamination and Impact on Maternal Health
An innovative, real-world experiment to evaluate the effects of exposure to per- and polyfluoroalkyl compounds (PFAS) on maternal health and fetal development, and raise awareness at the community level in North Carolina and around the globe, is the focus of the work led by Liping Feng, MD, of Duke Ob/Gyn’s Division of Reproductive Sciences and an affiliate of the Duke Global Health Institute. Her research looks at PFAS mixtures mimicking real-life exposures, not just the effects of single PFAS compounds in isolation.